Splanchnic venous thrombosis may suggest undiagnosed cancer
the ONA take:
According to a new study published in the journal Blood, researchers have found that a blood clot in an abdominal vein may suggest undiagnosed cancer, and these clots may indicate reduced survival in patients with liver and pancreatic cancer.
For the study, researchers analyzed the risk for subsequent cancer diagnosis of 1,191 Danish patients who were diagnosed with abdominal clots and evaluated the survival of those with a splanchnic venous thrombosis (SVT) and cancer versus those without cancer.
Results showed that compared with the general Danish population, patients who developed an SVT were 33 times more likely to be diagnosed with cancer during the first 3 months after SVT diagnosis. In addition, patients with an SVT and liver or pancreatic cancer had a significantly worse 3-month survival compared with those without an SVT.
Researchers also found that patients diagnosed with an SVT were more likely to develop a myeloproliferative neoplasm beyond 12 months after SVT diagnosis.
A blood clot in an abdominal vein may suggest undiagnosed cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|